Exxon Mobil Corp. and Chevron Corp. missed profit and production estimates as wildfires, writedowns and weak refining margins battered oil explorers already reeling under a glut-driven price collapse.
The third time isn't the charm. Or the fourth. Or the fifth. Or, apparently, the sixth or seventh. Earlier this month, the U.S.
Seres Therapeutics Inc. shares lost three quarters of their value Friday after the biotechnology company said its lead experimental drug failed in a clinical trial testing it against hard-to-treat intestinal infections.
Just two years ago, the sole story of Amazon's second quarter would have been the nearly $900 million in profit that it generated.
Analysts were cautiously optimistic, emphasis on the caution, Friday morning after Alphabet delivered a big earnings beat. There were plenty of reasons for optimism, as Alphabet beat earnings expectations on the strength of Google's ad business ...